- Aurora Cannabis (TSX:ACB) announced the discovery of PM2, a new source of genetic resistance for cannabis plants against powdery mildew
- The company is experimenting with powdery-mildew-resistant cultivars for a potential commercial launch in 2025
- Aurora is a global cannabis company serving both the medical and consumer markets across Canada, Europe, Australia and South America
- Aurora Cannabis stock has added 27.91 per cent year-over-year but remains down by 94.76 per cent since 2020
Aurora Cannabis (TSX:ACB) announced the discovery of PM2, a new source of genetic resistance for cannabis plants against powdery mildew, a common industry risk that can wipe out 10-15 per cent of a crop when it arises.
“This discovery offers a critical solution to a pressing challenge in the cannabis industry worldwide,” Lana Culley, vice president of innovation and international operations at Aurora,…
